Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thromboxane A2 synthesis in human erythroleukemia cells.

D A Jones1, F A Fitzpatrick, K C Malcolm

  • 1Department of Pharmacology, University of Colorado Health Sciences Center, Denver 80262.

Biochemical and Biophysical Research Communications
|October 15, 1991
PubMed
Summary

Human erythroleukemia cells can produce thromboxane A2 from external sources but cannot release internal arachidonic acid. This indicates a specific enzymatic capacity for thromboxane synthesis, confirmed by gene analysis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Waterloo Differential Acuity Test (WatDAT)-Testability and normative data.

Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)·2025
Same author

Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

Discharge after primary percutaneous coronary intervention: the earlier the better?

European heart journal. Quality of care & clinical outcomes·2021
Same author

Use of enhanced stent visualisation compared to angiography alone to guide percutaneous coronary intervention.

International journal of cardiology·2020
Same author

The Noncanonical Pathway for In Vivo Nitric Oxide Generation: The Nitrate-Nitrite-Nitric Oxide Pathway.

Pharmacological reviews·2020
Same author

Long-Term Endurance and Power Training May Facilitate Motor Unit Size Expansion to Compensate for Declining Motor Unit Numbers in Older Age.

Frontiers in physiology·2019

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Background:

  • Thromboxane A2 (TXA2) is a potent mediator involved in platelet aggregation and vasoconstriction.
  • Understanding the synthesis and regulation of TXA2 in various cell types is crucial for cardiovascular research.

Purpose of the Study:

  • To investigate the capacity of human erythroleukemia cells to synthesize thromboxane A2.
  • To determine if these cells possess the enzymatic machinery for endogenous arachidonic acid release and subsequent TXA2 production.

Main Methods:

  • Incubation of human erythroleukemia cells with exogenous arachidonic acid and prostaglandin endoperoxide H2.
  • Stimulation of cells with calcium ionophore A23187 and thrombin.
  • Labeling cells with [3H]-arachidonic acid to track endogenous release.

Related Experiment Videos

  • Detection of thromboxane A2 formation.
  • Verification of thromboxane synthase gene expression using reverse transcription polymerase chain reaction (RT-PCR) and cDNA sequencing.

    • Main Results:

    • Human erythroleukemia cells successfully converted exogenous arachidonic acid and prostaglandin endoperoxide H2 into thromboxane A2.
    • Stimulation with A23187 or thrombin did not induce thromboxane A2 production.
    • No detectable release of [3H]-arachidonic acid was observed upon cell stimulation.
    • Thromboxane synthase messenger RNA was detected, and sequence analysis of the cDNA showed high identity to known sequences.

    Conclusions:

    • Human erythroleukemia cells possess the enzymatic capability to synthesize thromboxane A2 from external precursors.
    • These cells lack the endogenous mechanisms required for the release of arachidonic acid, a key step in initiating TXA2 synthesis from internal stores.
    • The presence of thromboxane synthase mRNA confirms the genetic basis for TXA2 production in these cells, despite the absence of stimulus-induced release.